Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Adams

Showing results (311-320 of 370) with videos related to

Pageof 37
Sort By:
Circulation|December 28, 2018
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated AmyloidosisScott D Solomon, David Adams, Arnt Kristen, et al.
Orphanet Journal of Rare Diseases|April 2, 2024
Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1AShahram Attarian, Peter Young, Thomas H Brannagan, et al.
The New England Journal of Medicine|September 26, 2025
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with PolyneuropathyJulian D Gillmore, Ed Gane, Jörg Täubel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 25, 2020
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathiesGuillaume Fargeot, Corinne Dupel-Pottier, Maeva Stephant, et al.
The British Journal of Dermatology|March 4, 2026
Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alphaKirsty Hodgson, Joseph Inns, Gary Reynolds, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 19, 2021
Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primatesAlireza Hassani Najafabadi, Zeynab Izadi Najaf Abadi, Marisa E Aikins, et al.
Circulation. Cardiovascular Imaging|February 20, 2024
Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal StudyHooman Fazlalizadeh, Muhammad Shahzeb Khan, Ervin R Fox, et al.
Journal of Neurology|November 16, 2019
Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisAlejandra González-Duarte, John L Berk, Dianna Quan, et al.
JACC. Cardiovascular Interventions|October 30, 2023
1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study ResultsFiras Zahr, Howard K Song, Scott Chadderdon, et al.
Journal of Neurology|February 8, 2020
Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisAlejandra González-Duarte, John L Berk, Dianna Quan, et al.
Pageof 37

Showing results (311-320 of 370) with videos related to

Sort By:
Pageof 37
Circulation|December 28, 2018
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated AmyloidosisScott D Solomon, David Adams, Arnt Kristen, et al.
Orphanet Journal of Rare Diseases|April 2, 2024
Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1AShahram Attarian, Peter Young, Thomas H Brannagan, et al.
The New England Journal of Medicine|September 26, 2025
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with PolyneuropathyJulian D Gillmore, Ed Gane, Jörg Täubel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 25, 2020
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathiesGuillaume Fargeot, Corinne Dupel-Pottier, Maeva Stephant, et al.
The British Journal of Dermatology|March 4, 2026
Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alphaKirsty Hodgson, Joseph Inns, Gary Reynolds, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 19, 2021
Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primatesAlireza Hassani Najafabadi, Zeynab Izadi Najaf Abadi, Marisa E Aikins, et al.
Circulation. Cardiovascular Imaging|February 20, 2024
Closing the Last Mile Gap in Access to Multimodality Imaging in Rural Settings: Design of the Imaging Core of the Risk Underlying Rural Areas Longitudinal StudyHooman Fazlalizadeh, Muhammad Shahzeb Khan, Ervin R Fox, et al.
Journal of Neurology|November 16, 2019
Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisAlejandra González-Duarte, John L Berk, Dianna Quan, et al.
JACC. Cardiovascular Interventions|October 30, 2023
1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study ResultsFiras Zahr, Howard K Song, Scott Chadderdon, et al.
Journal of Neurology|February 8, 2020
Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosisAlejandra González-Duarte, John L Berk, Dianna Quan, et al.
Pageof 37